These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25011277)

  • 1. [Analysis on influential factors in China's exports of primary and semi-finished products of traditional Chinese medicine to ASEAN].
    Qian YX; Yang Y; Zhao W; Bi KS
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1321-5. PubMed ID: 25011277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cultivation strategy and path analysis on big brand Chinese medicine for small and medium-sized enterprises].
    Wang YY; Yang HJ
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):755-8. PubMed ID: 25204160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of industry promotion technology system in Chinese medicine secondary exploitation based on "component structure theory"].
    Cheng XD; Feng L; Zhang MH; Gu JF; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):4065-9. PubMed ID: 25751964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Formation and evolution of commodity specification and grade of traditional Chinese medicine].
    Li PY; Wang HY; Li J; Zhan ZL; Yang G
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):764-768. PubMed ID: 28875625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on competitiveness of traditional Chinese medicine industry's international trade based on diamond theory].
    Cheng M; Yang G; Chi XL; Xin MT
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(1):199-203. PubMed ID: 30868833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis and design of signaling transfer mechanism based on third-party certification: quality prestige index of traditional Chinese medicine enterprises].
    Yang G; Wang N; Guo LP; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):925-8. PubMed ID: 25204192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. There "ain't no mountain high enough"?: The drivers, diversity and sustainability of China's Rhodiola trade.
    Cunningham AB; Li HL; Luo P; Zhao WJ; Long XC; Brinckmann JA
    J Ethnopharmacol; 2020 Apr; 252():112379. PubMed ID: 31743765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on standards of commodity classes of Chinese materia medica and discussion on several key problems].
    Yang G; Zeng Y; Guo LP; Huang LQ; Jin Y; Zheng YG; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1733-8. PubMed ID: 25095394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on status of criteria for formulating specification and grade of Chinese medicinal materials based on filed survey in medicine market].
    Yang G; Wang N; Zhan ZL; Wang HY; Jin Y
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):761-763. PubMed ID: 28875624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brief introduction of research methods of commodity specification and grade of Chinese medicinal materials].
    Zhao HY; Yan PP; Yang WH; Li CF; Qi SY; Li YQ; Cao JL
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):765-9. PubMed ID: 26137705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on ginseng trade competitiveness between China and Korea].
    Xin MT; Yang G; Tang XJ
    Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1803-1807. PubMed ID: 29082711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection].
    Yang X; Xiao S; Guo Z; Wang Z; You Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):9-12. PubMed ID: 22741453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Import and export of licorice and its products in China].
    Ma S; Wang N; Yang G; Que L
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(11):2193-2199. PubMed ID: 28822168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trading Kuznets curve: empirical analysis for China.
    Yasar E; Akalin G; Erdogan S; Sarkodie SA
    Empirica (Dordr); 2022; 49(3):741-768. PubMed ID: 35818537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on early-warning of Chinese materia medica price base on ARMA model].
    Chang F; Mao YD
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1721-3. PubMed ID: 25095391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innovation guidelines and strategies for pharmaceutical engineering of Chinese medicine and their industrial translation].
    Cheng YY; Qu HB; Zhang BL
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):3-5. PubMed ID: 23596865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and countermeasures in developing traditional Chinese medicine in Europe.
    Liu Y; Yang Z; Cheng J; Fan D
    Front Med; 2016 Sep; 10(3):360-76. PubMed ID: 27465827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status and thinking of supervision and management of Chinese herbal medicine].
    Xie XY
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1832-5. PubMed ID: 24010306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overview of traditional Chinese medicine quality evaluation method based on overall research].
    Jiang H; Gao Y; Yang JM; Meng XC
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1027-31. PubMed ID: 26226739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chinese Sanqi industry status and development countermeasures].
    Cui XM; Huang LQ; Guo LP; Liu DH
    Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(4):553-7. PubMed ID: 25204122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.